BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 8864609)

  • 21. [On the effect of different antieczematic agents on the normal skin of guinea pigs. 3. Tars and shale oils in low concentration].
    Salfeld K; Rupec M; Hoos I
    Arch Klin Exp Dermatol; 1966 Apr; 224(4):392-401. PubMed ID: 4383350
    [No Abstract]   [Full Text] [Related]  

  • 22. Coal tar: past, present and future.
    Thami G; Sarkar R
    Clin Exp Dermatol; 2002 Mar; 27(2):99-103. PubMed ID: 11952698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antifungal activity of sulfonated shale oils].
    Listemann H; Schölermann A; Meigel W
    Arzneimittelforschung; 1993 Jul; 43(7):784-8. PubMed ID: 8103661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low concentration dithranol and coal tar (Psorin) in psoriasis: a comparison with alcoholic coal tar extract and allantoin (Alphosyl).
    Harrington CI
    Br J Clin Pract; 1989 Jan; 43(1):27-9. PubMed ID: 2590619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tar.
    Arnold WP
    Clin Dermatol; 1997; 15(5):739-44. PubMed ID: 9313972
    [No Abstract]   [Full Text] [Related]  

  • 26. No increased risk of cancer after coal tar treatment in patients with psoriasis or eczema.
    Roelofzen JH; Aben KK; Oldenhof UT; Coenraads PJ; Alkemade HA; van de Kerkhof PC; van der Valk PG; Kiemeney LA
    J Invest Dermatol; 2010 Apr; 130(4):953-61. PubMed ID: 20016499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of calcipotriene (Dovonex) with a coal tar emulsion (Exorex) in treating psoriasis in adults: a pilot study.
    Veronikis IE; Malabanan AO; Holick MF
    Arch Dermatol; 1999 Apr; 135(4):474-5. PubMed ID: 10206065
    [No Abstract]   [Full Text] [Related]  

  • 28. Managing a common disorder in children: Atopic dermatitis.
    Cheigh NH
    J Pediatr Health Care; 2003; 17(2):84-8; quiz 89-90. PubMed ID: 12665731
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum Level of Antibodies (IgG, IgM) Against Benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA Adducts in Children Dermatologically Exposed to Coal Tar.
    Borský P; Andrýs C; Krejsek J; Hamáková K; Kremláček J; Málková A; Bartošová L; Fiala Z; Palička V; Borská L
    Acta Medica (Hradec Kralove); 2017; 60(1):27-31. PubMed ID: 28467299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experiences in half-side treatment with tar additive to cignolin-salicylic-acid-white-vaseline therapy of psoriasis vulgaris].
    Schulze HJ; Steigleder GK
    Z Hautkr; 1984 May; 59(10):654-6. PubMed ID: 6741204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Final safety assessment of Coal Tar as used in cosmetics.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2008; 27 Suppl 2():1-24. PubMed ID: 18830861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Out-patient treatment of atopic dermatitis with crude coal tar.
    van der Valk PG; Snater E; Verbeek-Gijsbers W; Duller P; van de Kerkhof PC
    Dermatology; 1996; 193(1):41-4. PubMed ID: 8864617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of clobetasol propionate cream plus coal tar vs. topical psoralen and solar ultraviolet A therapy in palmoplantar psoriasis.
    Khandpur S; Sharma VK
    Clin Exp Dermatol; 2011 Aug; 36(6):613-6. PubMed ID: 21507036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An assessment of high and low temperature tars in Psoriasis.
    Chapman RS; Finn OA
    Br J Dermatol; 1976 Jan; 94(1):71-4. PubMed ID: 1252342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formation of DNA adducts in the skin of psoriasis patients, in human skin in organ culture, and in mouse skin and lung following topical application of coal-tar and juniper tar.
    Schoket B; Horkay I; Kósa A; Páldeák L; Hewer A; Grover PL; Phillips DH
    J Invest Dermatol; 1990 Feb; 94(2):241-6. PubMed ID: 2299199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occlusive tar extract therapy for recalcitrant psoriasis and seborrheic dermatitis of the scalp.
    Garcia RL; Miller JD; Miller WN
    Cutis; 1978 Jul; 22(1):90-1. PubMed ID: 149652
    [No Abstract]   [Full Text] [Related]  

  • 37. Coal tars and coal-tar pitches.
    National Toxicology Program
    Rep Carcinog; 2011; 12():111-3. PubMed ID: 21850131
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
    Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
    Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical tazarotene vs. coal tar in stable plaque psoriasis.
    Kumar U; Kaur I; Dogra S; De D; Kumar B
    Clin Exp Dermatol; 2010 Jul; 35(5):482-6. PubMed ID: 19874376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carcinogenicity of oil shale tars, some of their components, and commercial products.
    Bogovski PA; Vinkmann F
    Environ Health Perspect; 1979 Jun; 30():165-9. PubMed ID: 446447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.